Rani Therapeutics Stock Quote RANI - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.22

Bid

5.20

Ask

5.49

Volume

114,459

5.01 Day's Range 5.735

1.82 52 Week Range 8.75

Market Cap

261.482M

Previous Close

5.46

Open

5.52

Last Trade

5.2

Last Trade Time

Financial Volume

$ 625,213

VWAP

5.4623

Average Volume (3m)

155,943

Shares Outstanding

49,996,508

Dividend Yield

PE Ratio

-7.70

Earnings Per Share (EPS)

-0.68

Revenue

Net Profit

-33.97M

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ranitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $5.46. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

Rani Therapeutics currently has 49,996,508 shares outstanding. The market capitalization of Rani Therapeutics is $261.48 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -7.70.

Rani Therapeutics to Participate in May Investor Conferences

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.43	-21.5037593985	6.65	6.9	5.01	108344	5.78427377	CS
4	-0.54	-9.375	5.76	7.88	5.01	161000	6.70447453	CS
12	2.05	64.6687697161	3.17	8.75	2.85	155943	5.74554262	CS
26	3.23	162.311557789	1.99	8.75	1.9	128853	4.64785695	CS
52	1.13	27.6283618582	4.09	8.75	1.82	91646	4.28164747	CS
156	-6.04	-53.6412078153	11.26	36.27	1.82	85960	11.20336676	CS
260	-6.04	-53.6412078153	11.26	36.27	1.82	85960	11.20336676	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.49M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M